SPHERA FUNDS MANAGEMENT LTD. - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$8,088,000
+72.4%
753,037
+53.3%
0.86%
+119.5%
Q3 2021$4,691,000
-23.5%
491,159
+84.8%
0.39%
-27.7%
Q4 2020$6,136,000
-65.1%
265,753
-78.6%
0.54%
-68.4%
Q3 2020$17,559,000
-28.5%
1,243,550
-23.6%
1.72%
-25.3%
Q2 2020$24,559,000
+31.7%
1,628,550
-19.3%
2.31%
-0.9%
Q1 2020$18,643,000
-31.6%
2,017,624
-28.0%
2.33%
+3.7%
Q4 2019$27,275,000
+16.1%
2,800,320
-4.4%
2.25%
-38.1%
Q3 2019$23,501,000
-25.0%
2,930,320
+16.7%
3.63%
-15.3%
Q2 2019$31,329,000
-7.4%
2,510,320
+0.9%
4.29%
+38.8%
Q1 2019$33,838,000
+44.3%
2,488,078
+1.6%
3.09%
+16.9%
Q4 2018$23,452,000
+8.5%
2,447,994
+36.9%
2.64%
+6.5%
Q3 2018$21,617,000
+16.4%
1,787,994
+50.4%
2.48%
-3.1%
Q2 2018$18,573,000
-33.1%
1,189,056
-35.6%
2.56%
-39.2%
Q1 2018$27,759,000
+75.4%
1,845,704
+67.8%
4.22%
+127.0%
Q4 2017$15,829,000
+149.9%
1,100,000
+161.9%
1.86%
+105.4%
Q3 2017$6,334,000
+57.2%
420,000
+5.0%
0.90%
+32.2%
Q2 2017$4,028,000
+13.0%
400,000
-20.0%
0.68%
-1.9%
Q1 2017$3,565,000
-1.7%
500,000
-31.5%
0.70%
-24.1%
Q4 2016$3,628,000
-45.8%
730,000
-19.3%
0.92%
-15.8%
Q3 2016$6,697,000
+22.1%
905,000
-10.0%
1.09%
-23.5%
Q2 2016$5,487,000
+116.4%
1,005,000
+235.0%
1.42%
+159.6%
Q1 2016$2,535,000
-41.5%
300,000
-3.2%
0.55%
-0.7%
Q3 2015$4,337,000
-31.9%
310,000
-31.1%
0.55%
-11.4%
Q2 2015$6,368,000
+30.1%
450,0000.0%0.62%
+22.4%
Q1 2015$4,896,000
+7.0%
450,000
-18.2%
0.51%
-34.6%
Q4 2014$4,576,000550,0000.78%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,114,043$116,817,0007.46%
Parametrica Management Ltd 597,279$6,899,0006.86%
Redmile Group, LLC 22,716,086$262,371,0005.96%
Perceptive Advisors 53,118,886$613,524,0004.73%
Asymmetry Capital Management, L.P. 716,709$8,278,0004.39%
CM Management, LLC 450,000$5,198,0003.93%
Avoro Capital Advisors LLC 18,500,000$213,675,0003.64%
Kynam Capital Management, LP 573,699$6,626,0003.54%
SECTORAL ASSET MANAGEMENT INC 1,242,882$14,355,0002.16%
Ghost Tree Capital, LLC 500,000$5,775,0002.07%
View complete list of AMICUS THERAPEUTICS INC shareholders